Effect of Ginger Extract and/or Fenofibrate on the Associated Infertility of Experimentally Induced Obese Wistar Albino Male Rats

Ginger and fenofibrate each reversed obesity-induced sperm and hormone deficits in rats — no human data exists

Journal: Reproductive Biology | Published: 2026-03-20 | Type: Journal Article | PMID: 41861450 Authors: Mohamed M.H. et al. (Kafrelsheikh University, Alexandria University, Mansoura University — all veterinary medicine faculties, Egypt) Funding/COI: Funding not declared; no competing interests stated

Summary

Fifty male Wistar rats fed a high-fat diet for 16 weeks developed measurable reproductive deficits — lower testosterone, worse sperm parameters, elevated oxidative stress — and all three intervention groups (ginger alone, fenofibrate alone, combination) partially reversed those deficits. This is a veterinary animal study with a sample of 10 rats per group. Nothing here translates directly to human clinical practice.

Claims

• High-fat diet significantly decreased serum FSH, LH, and testosterone, plus sperm motility, morphology, and count versus normal controls
• High-fat diet significantly increased leptin, total cholesterol, triglycerides, LDL, VLDL, testicular MDA (oxidative stress marker), and aromatase gene expression
• All three treatment groups (ginger 300 mg/kg/day, fenofibrate 100 mg/kg/day, combination) showed significantly higher HDL, CAT, and SOD (antioxidant enzymes) and better sperm characteristics versus high-fat diet controls
• All three treatment groups showed reduced NF-κB p65 nuclear expression (inflammation) and caspase-3 expression (apoptosis) in testicular tissue
• Combination (HFDGF) group results reported but the abstract does not state whether combination was superior to either monotherapy

Study Quality

Ten rats per group is underpowered for detecting anything other than large effect sizes — the study can demonstrate a signal exists, not characterize its magnitude reliably. The 16-week high-fat diet model is a standard rodent obesity induction protocol, so the pathology model is reasonable. Multi-modal assessment is a genuine strength: the authors measured hormones, lipids, sperm parameters, oxidative stress markers, testicular histology, immunohistochemistry (NF-κB, caspase-3), and aromatase gene expression. That's a thorough mechanistic workup for a preclinical study.

The ginger dose of 300 mg/kg/day in rats does not translate straightforwardly to a human equivalent. Allometric scaling from rat to human typically involves a ~6x reduction factor, which would suggest a rough human equivalent of ~50 mg/kg/day — far above typical dietary ginger consumption. The paper does not address dose translation.

Red Flags

• Rats, not humans: obesity-induced infertility mechanisms overlap but are not identical; rat spermatogenesis differs from human
• n=10 per group — severely underpowered for clinical inference
• Funding source not declared — unknown whether industry interest exists in fenofibrate for this indication
• All authors from Egyptian veterinary medicine departments; this is explicitly veterinary research, not clinical medicine
• Abstract does not report actual hormone or sperm values with confidence intervals — only "significantly decreased/increased" language, which obscures effect sizes
• No dose-response data; single dose levels chosen for both compounds without justification
• No head-to-head comparison between ginger and fenofibrate quantified in abstract

Strengths

• Mechanistic depth: measured antioxidant enzymes, inflammatory signaling (NF-κB), apoptotic markers (caspase-3), and aromatase expression alongside functional endpoints
• Well-controlled design with both positive-control arms and a combination arm
• Histological and immunohistochemical analysis adds tissue-level confirmation beyond serum markers
• Fenofibrate is a known lipid-lowering agent, making its inclusion as a comparator pharmacologically grounded

Verdict

This is a competent small-animal mechanistic study that confirms ginger and fenofibrate can partially reverse obesity-induced reproductive dysfunction in rats via antioxidant and anti-inflammatory pathways — findings consistent with prior rodent literature on both compounds. It contributes nothing to human clinical evidence. The n=10 groups, absent funding disclosure, and non-translatable dosing make it a hypothesis-generator at best. File it under "plausible mechanism, needs human data before anyone cares."